Reply to the letter to the editor 'Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies'

Affiliations

• ¹ Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. Electronic address: [email protected].
• ² Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens; Frontier Science Foundation-Hellas, Athens, Greece.
• ³ Methodology Direction, EORTC Headquarters, Brussels, Belgium.
• ⁴ ESMO Head Office, Lugano, Switzerland.
• ⁵ Medical Oncology Department, Ioannina University Hospital, Ioannina, Greece.
• ⁶ Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
• ⁷ Division of Oncology, Medical University Vienna, Vienna, Austria.
• ⁸ Jules Bordet Institute, Universite Libre de Bruxelles, Brussels, Belgium.
• ⁹ Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.